Lumican and Versican Are Associated with Good Outcome in Stage II and III Colon Cancer

by de Wit, Meike, Belt, Eric J. Th., Delis-van Diemen, Pien M., Carvalho, Beatriz, Coupé, Veerle M. H., Stockmann, Hein B. A. C., Bril, Herman, Beliën, Jeroen A. M., Fijneman, Remond J. A., Meijer, Gerrit A.
Published 2012

A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9

by Goos, Jeroen A.C.M., Coupé, Veerle M.H., van de Wiel, Mark A., Diosdado, Begoña, Delis-Van Diemen, Pien M., Hiemstra, Annemieke C., de Cuba, Erienne M.V., Beliën, Jeroen A.M., Menke - van der Houven van Oordt, C. Willemien, Geldof, Albert A., Meijer, Gerrit A., Hoekstra, Otto S., Fijneman, Remond J.A.
Published 2015

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence

by den Uil, Sjoerd H, Coupé, Veerle M H, Linnekamp, Janneke F, van den Broek, Evert, Goos, Jeroen A C M, Delis-van Diemen, Pien M, Belt, Eric J Th, van Grieken, Nicole C T, Scott, Patricia M, Vermeulen, Louis, Medema, Jan Paul, Bril, Herman, Stockmann, Hein B A C, Cormier, Robert T, Meijer, Gerrit A, Fijneman, Remond J A
Published 2016

MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients

by Lenos, Kristiaan, Goos, Jeroen A.C.M., Vuist, Ilona M., den Uil, Sjoerd H., Delis-van Diemen, Pien M., Belt, Eric J.Th., Stockmann, Hein B.A.C., Bril, Herman, de Wit, Meike, Carvalho, Beatriz, Giblett, Susan, Pritchard, Catrin A., Meijer, Gerrit A., van Kooyk, Yvette, Fijneman, Remond J.A., van Vliet, Sandra J.
Published 2015